FDA — authorised 24 September 1971
- Marketing authorisation holder: B BRAUN
- Status: approved
🇺🇸 Procalamine in United States
FDA authorised Procalamine on 24 September 1971
Marketing authorisations
FDA — authorised 6 May 1982
- Application: NDA018582
- Marketing authorisation holder: B BRAUN
- Local brand name: PROCALAMINE
- Indication: INJECTABLE — INJECTION
- Status: approved
Procalamine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Procalamine approved in United States?
Yes. FDA authorised it on 24 September 1971; FDA authorised it on 6 May 1982.
Who is the marketing authorisation holder for Procalamine in United States?
B BRAUN holds the US marketing authorisation.